Featured
Theia Buys 4 Unsubsidized Photovoltaic Plants Under Construction from NatPower
At the end of March, Theia Investments secured a $33.8 million (€32 million) loan from BPER Banca for seven Italian photovoltaic plants, with a total capacity of around 17 MW. Also at the end of March, subsidiary Theia Investments (Italy) srl completed the acquisition of a vehicle company owning two photovoltaic plants, for a total of 10.1 MW in Sardinia, reaching the threshold of 30MW total in the portfolio.
Theia Holdings, a leading British operator in the production of electricity from renewable sources, has bought from NatPower two spvs owning four photovoltaic plants under construction in Piedmont for a total capacity of 22 MW.
L&B assisted Theia on the legal side, while Kiwa Moroni assisted Theia in the role of technical advisor. Prothea acted as NatPower’s exclusive financial advisor, while the law firm Gattai, Minoli was the legal advisor.
If you want to find more details about Theia Investments and to read the latest business headlines of the day, download for free our companion app. The Born2Invest business news application will bring you the latest, breaking news from a trusted global network of journalists. Updated throughout the day, Born2Invest is a professionally curated digest of business, finance, and crypto news summaries from the most reputable news organizations around the world.
Theia already has a rich portfolio in Italy
Based in Milan and London, NatPower is an independent company specializing in investments in renewable energy and sustainable infrastructure, led by CEO and partner Fabrizio Zago (former president and CEO of Building Energy) and partners Matteo Racchelli (coo), Carmine Fioravante (CTO) and Matteo Ballini (CFO).
Theia Investments team commented: “This deal represents a real milestone for Theia, being the first acquisition of unsubsidized plants in our portfolio. We would like to thank the entire advisory team for their exceptional support in this complex transaction.”
Theia already has a rich portfolio in Italy. At the end of March, it secured a $33.8 million (€32 million) loan from BPER Banca for seven Italian photovoltaic plants, with a total capacity of around 17 MW. Also at the end of March, subsidiary Theia Investments (Italy) srl completed the acquisition of a vehicle company owning two photovoltaic plants, for a total of 10.1 MW in Sardinia, reaching the threshold of 30MW total in the portfolio.
Previously, in July 2021, the subsidiary Theia Investments (Italy) 3 srl had taken over three photovoltaic plants in Apulia for a total of 3 MW (see press release here), while in June it had taken over a 3 MW portfolio of photovoltaic greenhouses in Sardinia from a group of entrepreneurs, and in March it had taken over a 1 MW rooftop photovoltaic plant in Piedmont.
In February 2021, the same vehicle had taken over a 1 MW photovoltaic plant in Puglia from private individuals. Also in February 2021, Theia Investments obtained from Intesa Sanpaolo a loan of approximately $43.4 million (€41 million) for 23 photovoltaic plants in Italy. In 2020, Theia had also purchased 10 photovoltaic plants in Italy. In December 2019, on the other hand, Theia had acquired two photovoltaic plants.
Backed by institutional investors, Theia is a management company focused on the acquisition and management of renewable energy assets in Europe. Theia’s management team, led by investment manager Porfirio Squadrone, has been involved in the development, construction, and acquisition of over one GWp of renewable energy plants.
__
(Featured image by fabersam via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BeBeez, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech1 week ago
Laminar Pharma Raises 5.9 Million in a New Round of Financing
-
Crypto16 hours ago
Bitcoin ETF Options Debut in the U.S.: Is a New All-Time High on the Horizon?
-
Biotech2 weeks ago
Leitat Purchases ReadyCell through MedTech Innovation on Advanced Medicine
-
Fintech7 days ago
Metadev3 Now Becomes a Validator on Tezos